Mankind Pharma Q2 Results

  • BSE: 543904
  • NSE: MANKIND
  • ISIN: INE634S01028
  • Sector: -
BSE
2,129-9.90 (-0.46%)
Volume42.97 K
Updated: Fri 19 Jul, 2024 | 15:49:15
NSE
2,129-9.85 (-0.46%)
Volume5.48 L
Updated: Fri 19 Jul, 2024 | 15:54:23
Today: 2,116.10
2,151.40
52-Wk: 1,680.50
2,488.65

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Mankind Pharma Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 2,708.102,578.625.02%
    Selling/ General/ Admin Expenses Total 571.96552.913.45%
    Depreciation/ Amortization 96.4887.3510.45%
    Other Operating Expenses Total 628.63550.9314.10%
    Total Operating Expense 2,121.942,011.165.51%
    Operating Income 586.16567.463.30%
    Net Income Before Taxes 640.99624.472.65%
    Net Income 501.03486.872.91%
    Diluted Normalized EPS 12.4912.152.80%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanBudget